Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T, Ejiri K, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Takaishi A, Kawai Y, Sato T, Sato K, Oka T, Takahashi N, Sakuragi S, Mima A, Enko K, Hosogi S, Nanba S, Hirami R, Nakamura K, Ito H; RINC Study Collaborators. Miyoshi T, et al. Among authors: ejiri k. Int J Cardiol. 2017 Jun 1;236:36-42. doi: 10.1016/j.ijcard.2017.02.028. Epub 2017 Feb 10. Int J Cardiol. 2017. PMID: 28214082 Clinical Trial.
Epoprostenol sodium for treatment of pulmonary arterial hypertension.
Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H. Saito Y, et al. Among authors: ejiri k. Vasc Health Risk Manag. 2015 May 14;11:265-70. doi: 10.2147/VHRM.S50368. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 25999730 Free PMC article. Review.
Epoprostenol Therapy for Pulmonary Arterial Hypertension.
Akagi S, Nakamura K, Matsubara H, Ogawa A, Sarashina T, Ejiri K, Ito H. Akagi S, et al. Among authors: ejiri k. Acta Med Okayama. 2015;69(3):129-36. doi: 10.18926/AMO/53519. Acta Med Okayama. 2015. PMID: 26101188 Free article. Review.
Feasibility of Repairing Defects Followed by Treatment with Pulmonary Hypertension-specific Drugs (Repair and Treat) in Patients with Pulmonary Hypertension Associated with Atrial Septal Defect: Study Protocol for Interventional Trial.
Akagi S, Nakamura K, Akagi T, Nakagawa K, Takaya Y, Sarashina T, Ejiri K, Ito H. Akagi S, et al. Among authors: ejiri k. Acta Med Okayama. 2016 Oct;70(5):397-400. doi: 10.18926/AMO/54600. Acta Med Okayama. 2016. PMID: 27777434 Free article. Clinical Trial.
Reverse Right Ventricular Remodeling After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Under Combination Therapy of Targeted Medical Drugs.
Sarashina T, Nakamura K, Akagi S, Oto T, Oe H, Ejiri K, Nakagawa K, Nishii N, Matsubara H, Kobayashi M, Morimatsu H, Miyoshi S, Ito H. Sarashina T, et al. Among authors: ejiri k. Circ J. 2017 Feb 24;81(3):383-390. doi: 10.1253/circj.CJ-16-0838. Epub 2017 Jan 18. Circ J. 2017. PMID: 28100891 Free article. Clinical Trial.
147 results